|
MLLT4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.482600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.110300E-02 |
| Normal-vs-Stage2 |
1.573850E-02 |
| Normal-vs-Stage3 |
1.364750E-03 |
| Normal-vs-Stage4 |
1.65674000000005E-05 |
| Stage1-vs-Stage2 |
3.776400E-01 |
| Stage1-vs-Stage3 |
1.434450E-01 |
| Stage1-vs-Stage4 |
7.424400E-03 |
| Stage2-vs-Stage3 |
7.057400E-01 |
| Stage2-vs-Stage4 |
1.848960E-01 |
| Stage3-vs-Stage4 |
2.970600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.978500E-03 |
| Normal-vs-AfricanAmerican |
1.852440E-02 |
| Normal-vs-Asian |
2.08950001745478E-09 |
| Caucasian-vs-AfricanAmerican |
9.941800E-01 |
| Caucasian-vs-Asian |
2.40810000051717E-07 |
| AfricanAmerican-vs-Asian |
7.3038000003578E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.238940E-03 |
| Normal-vs-Female |
1.578780E-01 |
| Male-vs-Female |
4.374400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.048200E-02 |
| Normal-vs-Extreme_Weight |
5.116900E-03 |
| Normal-vs-Obese |
7.339600E-02 |
| Normal-vs-Extreme_Obese |
1.023720E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.111600E-01 |
| Normal_Weight-vs-Obese |
4.700600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.662800E-01 |
| Extreme_Weight-vs-Obese |
2.650400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.213000E-01 |
| Obese-vs-Extreme_Obese |
3.855800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.287040E-01 |
| Normal-vs-Age(41-60Yrs) |
3.760400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.51320000000888E-05 |
| Normal-vs-Age(81-100Yrs) |
6.368100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.935000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.360600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.388200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.999900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.062240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.627000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.321400E-01 |
| Normal-VS-Type2 PRCC |
3.29310000379834E-08 |
| Normal-VS-KIRP CIMP |
8.449400E-04 |
| Normal-VS-Unclassified PRCC |
1.095000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.70029999996468E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.278000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.823400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.527800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.342400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.261200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78589999999534E-06 |
| Normal-vs-N1 |
6.565900E-04 |
| Normal-vs-N2 |
8.43130000000025E-05 |
| N0-vs-N1 |
4.093000E-01 |
| N0-vs-N2 |
1.083710E-03 |
| N1-vs-N2 |
3.969600E-04 |
|
|
